Thrive Capital Management (Pennsylvania)’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,494
Closed -$267K 157
2023
Q3
$267K Sell
8,494
-204
-2% -$6.72K 0.15% 107
2023
Q2
$289K Sell
8,698
-9,120
-51% -$312K 0.16% 99
2023
Q1
$629K Buy
17,818
+392
+2% +$14.8K 0.4% 53
2022
Q4
$697K Buy
17,426
+1,027
+6% +$40.4K 0.46% 46
2022
Q3
$582K Buy
16,399
+7,252
+79% +$291K 0.39% 49
2022
Q2
$393K Buy
+9,147
New +$392K 0.27% 59

Other funds holding BTI

Thrive Capital Management (Pennsylvania)'s BTI Position: Q4 2023 in Review

Thrive Capital Management (Pennsylvania) sold out of British American Tobacco (BTI) in Q4 2023, closing a stake of 8,494 shares — an estimated $267K sold.

Thrive Capital Management (Pennsylvania) first reported a position in BTI in Q2 2022 and held it in 6 quarters. The position peaked at $697K in Q4 2022. 549 funds tracked by Wall St. Rank hold BTI as of Q4 2023.

  • Thrive Capital Management (Pennsylvania) reported no remaining British American Tobacco position as of Q4 2023 after selling out during the quarter.
  • Thrive Capital Management (Pennsylvania) sold 8,494 British American Tobacco shares in Q4 2023, an estimated $267K.
  • Thrive Capital Management (Pennsylvania) first reported a position in British American Tobacco in Q2 2022 and held it in 6 quarters.
  • Thrive Capital Management (Pennsylvania)'s British American Tobacco position peaked at $697K in Q4 2022.
  • 549 funds tracked by Wall St. Rank held British American Tobacco as of Q4 2023.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q4 2023, filed 29 Jan 2024.